Peer Exchange

The Skidki-na-vse® Peer Exchange series is built around video panel discussions featuring some of the most recognizable names in pharmaceuticals. Each program focuses on a specific disease, condition, or therapy, and boasts energetic, moderated conversation on a variety of subjects and questions pertaining to the topic at hand.

What can we help you find?
The Future of Immunization Coverage & Administration
An overview of the advancements being made in the practice of immunization coverage and administration.
Barriers to Vaccine Screening and Administration
Troy Trygstad, PharmD, MBA, PhD, leads a discussion on the challenges in vaccine screening and administration, including a consideration of nonflu vaccines, the distribution process, reimbursement issues, and accessibility restrictions.
Raising Awareness on Booster Vaccines
A discussion on the importance of booster vaccines and how to effectively raise awareness to target populations.
ACIP Guidelines and Best Practice Recommendations
Experts in the field of immunization discuss screening and administration recommendations, with consideration of the ACIP Guidelines and APhA training program.
The Importance of Immunization Registries
Key opinion leaders discuss the importance of immunization registries and data surveys for pharmacists and technicians in identifying and reaching target populations.
Training Pharmacists and Technicians on Vaccine Policy
A discussion on how to effectively train pharmacists and technicians on immunization coverage, administration and follow-up.
Immunization Capture Points
Experts in the field of immunization discuss key vaccine capture points to bridge the treatment gap.
The Vaccination Population Gap and High-Risk Strata
A discussion regarding the population gap in vaccine coverage and the patient groups at high-risk if not immunized. 
The Immunization Treatment Landscape
Troy Trygstad, PharmD, MBA, PhD, leads a discussion on the current rates of immunization amongst various age groups and how to effectively administer vaccines to the general population.
Stratifying Patients With IBS-C to the Appropriate Agent
Following their discussion of available agents for irritable bowel syndrome with constipation (IBS-C), the panel considers how to optimally stratify patients.
Guanylate Cyclase-C Agonists for IBS-C
Experts break down the appropriate use of guanylate cyclase-C agonists for irritable bowel syndrome with constipation (IBS-C).
IBS-C Management: Laxatives and Lubiprostone
Switching their focus to irritable bowel syndrome with constipation (IBS-C), panelists evaluate the use of laxatives and lubiprostone, respectively.
+ Load More